Pacer Advisors Inc. Buys 17,623 Shares of Colgate-Palmolive (NYSE:CL)

Pacer Advisors Inc. grew its stake in Colgate-Palmolive (NYSE:CL) by 18.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 111,272 shares of the company’s stock after purchasing an additional 17,623 shares during the quarter. Pacer Advisors Inc.’s holdings in Colgate-Palmolive were worth $11,551,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of CL. Advisors Asset Management Inc. lifted its position in Colgate-Palmolive by 263.2% during the first quarter. Advisors Asset Management Inc. now owns 27,126 shares of the company’s stock worth $2,443,000 after acquiring an additional 19,657 shares during the last quarter. 1832 Asset Management L.P. increased its stake in shares of Colgate-Palmolive by 4,847.3% during the first quarter. 1832 Asset Management L.P. now owns 9,301 shares of the company’s stock worth $838,000 after purchasing an additional 9,113 shares during the period. SVB Wealth LLC lifted its holdings in Colgate-Palmolive by 2.7% during the 1st quarter. SVB Wealth LLC now owns 34,883 shares of the company’s stock worth $3,141,000 after purchasing an additional 920 shares during the last quarter. Industrial Alliance Investment Management Inc. boosted its stake in Colgate-Palmolive by 4.4% in the 1st quarter. Industrial Alliance Investment Management Inc. now owns 4,185 shares of the company’s stock valued at $377,000 after purchasing an additional 176 shares during the period. Finally, B. Riley Wealth Advisors Inc. grew its holdings in Colgate-Palmolive by 0.8% in the 1st quarter. B. Riley Wealth Advisors Inc. now owns 16,639 shares of the company’s stock valued at $1,498,000 after buying an additional 138 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Barclays boosted their target price on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Sanford C. Bernstein increased their target price on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research report on Tuesday, July 30th. TD Cowen dropped their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Monday, October 28th. UBS Group increased their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $105.11.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $94.92 on Friday. The company’s 50 day moving average price is $98.10 and its two-hundred day moving average price is $98.54. The firm has a market capitalization of $77.55 billion, a P/E ratio of 27.20, a P/E/G ratio of 3.36 and a beta of 0.42. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a fifty-two week low of $75.50 and a fifty-two week high of $109.30.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.11%. Colgate-Palmolive’s payout ratio is presently 57.31%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.